A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the ...
The U.S. Coast Guard's elite surfmen are trusted to drive lifeboats on the most challenging rescue missions. They train in ...
Come to starboard. On a wet February afternoon, we're on board a 47 foot U.S. Coast Guard motor lifeboat with Chief Eric Ceallaigh at the helm, driving through breaking surf barely a hundred yards ...
Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the company’s leadership. However, analysts are supportive of the embattled executive ...
Starboard Chief Executive Jeff Smith, whose fund has a roughly $1 billion stake in Pfizer, said Tuesday that the pharmaceutical company's board should be laser-focused on tracking its return on R ...
NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...
He also shared a version of the presentation his hedge fund Starboard presented to Pfizer officials at a meeting last week. "It's not often that investors and shareholders are able to see what we ...
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. Starboard has called on Pfizer’s board to “hold management ...
Activist describes Pfizer’s post-Covid share fall as ‘crazy’ Starboard also wants Kenvue to do more in skin and beauty Speaking at the 13D Monitor Active-Passive Investor Summit on Tuesday, Smith ...
Activist investor Starboard Value has sharpened its criticism of Pfizer Inc. (NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on its promises of ...
NEW YORK (Reuters) -Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold management accountable for its underperformance ...